To facilitate further data analysis, we employed appropriate critical values to divide LIHC tumor samples into high and low miR-101 expression groups, as well as high and low UBE2D1 expression groups, and then combined into four groups: miR-101highUBE2D1high, miR-101highUBE2D1low, miR-101lowUBE2D1high, miR-101lowUBE2D1low for survival comparison purposes. Here, UBE2D1 is linked to neoplasm.